bioMérieux S.A. (LON:0RUG)

bioMérieux Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	449.8	352.4	552.6	803.5	389.2
Cash & Short-Term Investments	449.8	352.4	552.6	803.5	389.2
Cash Growth	27.64%	-36.23%	-31.23%	106.45%	41.53%
Accounts Receivable	792.3	728.6	740.1	590.6	597.9
Other Receivables	146.4	131.7	116.6	118.3	84.2
Receivables	938.7	860.3	856.7	708.9	682.1
Inventory	1,037	908.5	737.2	620	541.9
Prepaid Expenses	33	38.6	31.4	23.9	20.7
Other Current Assets	42.3	45.4	38.8	36.2	27.6
Total Current Assets	2,501	2,205	2,217	2,193	1,662
Property, Plant & Equipment	1,696	1,506	1,370	1,225	1,069
Long-Term Investments	180.2	206	71.2	34.5	39.9
Goodwill	730.4	698.8	812.5	669.5	629.4
Other Intangible Assets	492	528.6	625	411.5	430.7
Long-Term Accounts Receivable	9.1	7.7	12.9	12.6	14.3
Long-Term Deferred Tax Assets	145.9	92.7	58.7	32	72.6
Other Long-Term Assets	0.1	-	-0.1	0.1	0.1
Total Assets	5,770	5,259	5,187	4,605	3,928
Accounts Payable	272.4	265.1	269.4	239.5	207.1
Accrued Expenses	451.6	378.7	372.7	318	327.4
Short-Term Debt	17.7	29	53.9	26.3	52.9
Current Portion of Long-Term Debt	94.4	107	106.9	48.6	51.6
Current Portion of Leases	29.4	27.4	26.2	24.8	24.4
Current Income Taxes Payable	35.4	52.8	49	67.4	44.3
Current Unearned Revenue	87.4	80.1	88.5	84	68.7
Other Current Liabilities	146.6	147.2	164.5	147.2	147.4
Total Current Liabilities	1,135	1,087	1,131	955.8	923.8
Long-Term Debt	206.6	234.2	224.7	265.2	249.2
Long-Term Leases	142.6	121.2	93.7	97.6	103.2
Long-Term Deferred Tax Liabilities	25.7	11.1	53	60.3	105.8
Other Long-Term Liabilities	49.2	53.2	41.2	62.5	64.4
Total Liabilities	1,559	1,507	1,544	1,441	1,446
Common Stock	12	12	12	12	12
Additional Paid-In Capital	3,667	3,420	3,062	2,532	63.7
Retained Earnings	432.2	357.6	452.4	601.1	404.4
Treasury Stock	-42.9	-19.1	-36	-10.3	-23.1
Comprehensive Income & Other	136.7	-18.5	113.6	-22.7	1,974
Total Common Equity	4,205	3,752	3,604	3,112	2,431
Minority Interest	6.1	-	38.7	51.4	50.2
Shareholders' Equity	4,211	3,752	3,643	3,164	2,481
Total Liabilities & Equity	5,770	5,259	5,187	4,605	3,928
Total Debt	490.7	518.8	505.4	462.5	481.3
Net Cash (Debt)	-40.9	-166.4	47.2	341	-92.1
Net Cash Growth	-	-	-86.16%	-	-
Net Cash Per Share	-0.34	-1.40	0.40	2.87	-0.78
Filing Date Shares Outstanding	117.93	118.16	117.92	118.25	118.14
Total Common Shares Outstanding	117.92	118.15	118	118.27	118.15
Working Capital	1,366	1,118	1,086	1,237	737.7
Book Value Per Share	35.66	31.76	30.54	26.32	20.58
Tangible Book Value	2,983	2,525	2,167	2,031	1,371
Tangible Book Value Per Share	25.29	21.37	18.36	17.17	11.61
Land	63.6	58.5	56.5	54.5	51.3
Buildings	954.2	845.5	823.5	742.7	645.9
Machinery	808	785.3	682.2	626.4	536.2
Construction In Progress	355.4	249.6	227.1	157.1	130

Source: S&P Global Market Intelligence. Standard template. Financial Sources.